International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer
M. Roumiguié, Ashish M. Kamat, Trinity J. Bivalacqua, Seth P. Lerner, Wassim Kassouf, Andreas Böhle, Maurizio Brausi, Roger Buckley, Raj Persad, Marc Colombel, Donald L. Lamm, J. Palou-Redorta, Mark S. Soloway, Ken Brothers, Gary D. Steinberg, Yair Lotan, Richard Sylvester, J. Alfred Witjes, Peter C. Black
Topics & Concepts
MedicineBladder cancerClinical trialClinical endpointInternal medicineRandomized controlled trialCarcinoma in situRandomizationClinical study designOncologyGemcitabineCohortCancerSurgeryBladder and Urothelial Cancer TreatmentsImmune responses and vaccinationsCancer Immunotherapy and Biomarkers